Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study

1. Sulkowski, M.S.
2. Fessel, W.J.
3. Lazzarin, A.
4. Berenguer, J.
5. Zakharova, N.
6. Cheinquer, H.
7. Côté, P.
8. Dieterich, D.
9. Gadano, A.
10. Matthews, G.
11. Molina, J.-M.
12. Moreno, C.
13. Pineda, J.A.
14. Pulido, F.
15. Rivero, A.
16. Rockstroh, J.
17. Hernandez, D.
18. McPhee, F.
19. Eley, T.
20. Liu, Z.
21. Mendez, P.
22. Hughes, E.
23. Noviello, S.
24. Ackerman, P.